Review




Structured Review

LabKey Corporation web-based graphical user interface
Web Based Graphical User Interface, supplied by LabKey Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based graphical user interface/product/LabKey Corporation
Average 90 stars, based on 1 article reviews
web-based graphical user interface - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
RStudio web-based graphical user interface biblioshiny
Web Based Graphical User Interface Biblioshiny, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based graphical user interface biblioshiny/product/RStudio
Average 90 stars, based on 1 article reviews
web-based graphical user interface biblioshiny - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Charite Research Organisation web-based graphical user interface
Web Based Graphical User Interface, supplied by Charite Research Organisation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based graphical user interface/product/Charite Research Organisation
Average 90 stars, based on 1 article reviews
web-based graphical user interface - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
LabKey Corporation web-based graphical user interface
Web Based Graphical User Interface, supplied by LabKey Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based graphical user interface/product/LabKey Corporation
Average 90 stars, based on 1 article reviews
web-based graphical user interface - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Virtua Drug web-based graphical user interface (gui) of dockingserver
Affinity purification of cellular targets of compound D. (A) Biotin linked to the R1 group of compound D. This compound was bound to streptavidin-agarose and used to affinity purify proteins from a trophozoite cell lysate. The only significant hit identified by LC-MS/MS was HSP90 (see Table S3 in the supplemental material). (B) Predicted interactions between compound D and PfHSP90. (C) Modeling of the most likely binding orientation of compound D to the ATP binding site of HSP90 was carried out using <t>DockingServer.</t> Residues predicted to form hydrogen bonds with compound D are labeled in green, while those predicted to form hydrophobic interactions are labeled in blue. (D) Recombinant PfHSP90 binds to compound D. Purified recombinant PfHSP90 and PfHSP90-NTD used in subsequent experiments are shown in the Coomassie-stained gels to the left of the figure. Changes in the tryptophan fluorescence (346 nm) of PfHSP90 were monitored in the presence of increasing amounts of compound D or 17-AAG. K d values were calculated for both full-length (FL) PfHSP90 and PfHSP90-NTD. Values in brackets are the standard errors (SE) of the means of triplicate measurements.
Web Based Graphical User Interface (Gui) Of Dockingserver, supplied by Virtua Drug, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based graphical user interface (gui) of dockingserver/product/Virtua Drug
Average 90 stars, based on 1 article reviews
web-based graphical user interface (gui) of dockingserver - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
RStudio web-based graphical user interface
Affinity purification of cellular targets of compound D. (A) Biotin linked to the R1 group of compound D. This compound was bound to streptavidin-agarose and used to affinity purify proteins from a trophozoite cell lysate. The only significant hit identified by LC-MS/MS was HSP90 (see Table S3 in the supplemental material). (B) Predicted interactions between compound D and PfHSP90. (C) Modeling of the most likely binding orientation of compound D to the ATP binding site of HSP90 was carried out using <t>DockingServer.</t> Residues predicted to form hydrogen bonds with compound D are labeled in green, while those predicted to form hydrophobic interactions are labeled in blue. (D) Recombinant PfHSP90 binds to compound D. Purified recombinant PfHSP90 and PfHSP90-NTD used in subsequent experiments are shown in the Coomassie-stained gels to the left of the figure. Changes in the tryptophan fluorescence (346 nm) of PfHSP90 were monitored in the presence of increasing amounts of compound D or 17-AAG. K d values were calculated for both full-length (FL) PfHSP90 and PfHSP90-NTD. Values in brackets are the standard errors (SE) of the means of triplicate measurements.
Web Based Graphical User Interface, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/web-based graphical user interface/product/RStudio
Average 90 stars, based on 1 article reviews
web-based graphical user interface - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Affinity purification of cellular targets of compound D. (A) Biotin linked to the R1 group of compound D. This compound was bound to streptavidin-agarose and used to affinity purify proteins from a trophozoite cell lysate. The only significant hit identified by LC-MS/MS was HSP90 (see Table S3 in the supplemental material). (B) Predicted interactions between compound D and PfHSP90. (C) Modeling of the most likely binding orientation of compound D to the ATP binding site of HSP90 was carried out using DockingServer. Residues predicted to form hydrogen bonds with compound D are labeled in green, while those predicted to form hydrophobic interactions are labeled in blue. (D) Recombinant PfHSP90 binds to compound D. Purified recombinant PfHSP90 and PfHSP90-NTD used in subsequent experiments are shown in the Coomassie-stained gels to the left of the figure. Changes in the tryptophan fluorescence (346 nm) of PfHSP90 were monitored in the presence of increasing amounts of compound D or 17-AAG. K d values were calculated for both full-length (FL) PfHSP90 and PfHSP90-NTD. Values in brackets are the standard errors (SE) of the means of triplicate measurements.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development

doi: 10.1128/AAC.01748-15

Figure Lengend Snippet: Affinity purification of cellular targets of compound D. (A) Biotin linked to the R1 group of compound D. This compound was bound to streptavidin-agarose and used to affinity purify proteins from a trophozoite cell lysate. The only significant hit identified by LC-MS/MS was HSP90 (see Table S3 in the supplemental material). (B) Predicted interactions between compound D and PfHSP90. (C) Modeling of the most likely binding orientation of compound D to the ATP binding site of HSP90 was carried out using DockingServer. Residues predicted to form hydrogen bonds with compound D are labeled in green, while those predicted to form hydrophobic interactions are labeled in blue. (D) Recombinant PfHSP90 binds to compound D. Purified recombinant PfHSP90 and PfHSP90-NTD used in subsequent experiments are shown in the Coomassie-stained gels to the left of the figure. Changes in the tryptophan fluorescence (346 nm) of PfHSP90 were monitored in the presence of increasing amounts of compound D or 17-AAG. K d values were calculated for both full-length (FL) PfHSP90 and PfHSP90-NTD. Values in brackets are the standard errors (SE) of the means of triplicate measurements.

Article Snippet: Docking calculations were performed using the web-based graphical user interface (GUI) of DockingServer by Virtua Drug (Budapest, Hungary) ( ).

Techniques: Affinity Purification, Liquid Chromatography with Mass Spectroscopy, Binding Assay, Labeling, Recombinant, Purification, Staining, Fluorescence